Moderna to Present at Two Major Investor Conferences in September

On September 14 and 23, 2026, biotech giant Moderna, Inc. (Nasdaq: MRNA) will present at two major investor conferences. The company will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, at 10:00 a.m. ET, and the Bernstein Insights: Healthcare Leaders and Disruptors 3rd Annual Healthcare Forum on Wednesday, September 23, at 8:50 a.m. ET.

Attendees at both conferences will have the opportunity to hear directly from Moderna's leadership team about the company's ongoing advancements and future plans. The presentations will be available live via webcast, and Moderna will maintain an archive of these webcasts on its website for at least 30 days post-presentation.

Moderna, a pioneer in mRNA medicine, continues to leverage its cutting-edge technology platform to develop innovative treatments and vaccines for a wide range of diseases, including infectious diseases, cancer, and rare diseases. The company’s commitment to transforming medicine through mRNA technology is evident in its diverse portfolio of products and ongoing research.

Moderna’s participation in these conferences underscores its active engagement with the investment community and its dedication to transparency and communication. The presentations will provide valuable insights into the company's strategic direction and recent achievements, allowing investors to stay informed about the latest developments in the field of mRNA technology.